SLC7A5 and glioma: Since LAT1 is the protein encoded by the SLC7A5 gene [22], we hypothesize that the higher TERT promoter mutation rate in neocortical gliomas may lead to increased LAT1 expression, which in turn enhances FET uptake and consequently increases metabolic activity.